Research
And Grants
To further our mission, we annually award research grants to institutions and medical professionals whose research focuses on cancers that present the greatest opportunities for a homerun cancer cure.
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
The Cure Starts Now has funded $21,325,827 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 135 grants at over 100 hospitals in 17 countries.

Institute of Cancer Research - $121,863
$121,863.00
November 2019
Targeting Top3A-Amplified DIPG cells by Sirtuin inhibition.

Bambino Gesu Children's Hospital - $49,803
$49,803.00
August 2019
Using imaging mass cytometry to identify next generation imaging biomarkers in PHGG and DIPG.

Telethon Kids Institute - $49,512
$49,512.00
August 2019
Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma.

Oncoceutics ONC201 - Phase II - $83,333
$83,333.00
May 2019
Expansion of the ONC201 Compassionate Use.

Funding of PBTCF 2019: PBTC-058 - $25,000
$25,000.00
January 2019
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

Sydney Children’s Hospital - $175,089
$175,089.00
November 2018
Polyamine Pathway Metabolism as a Novel Therapeutic Option for Diffuse Intrinsic Pontine Glioma

Cincinnati Children's Hospital - $540,742
$540,742.00
November 2018
Expansion of the International DIPG Registry.

Bambino Gesú Children's Hospital - $99,382
$99,382.00
November 2018
Investigating the Role of DIPG-Derived Exosomes in Tumor Growth and Invasion.

Ann and Robert H. Lurie Children's Hospital of Chicago - $35,000
$35,000.00
November 2018
Credentialing an Improved DIPG Mouse Model.

Oncoceutics ONC201 - $83,333
$83,333.00
October 2018
Expansion of the ONC201 Compassionate Use.

The Institute of Cancer Research - $100,000
$100,000.00
October 2018
Short-pulse Ultrasound Delivery of Panobinostat for the Treatment of Diffuse Intrinsic Gliomas in Children

The Institute of Cancer Research - $106,647
$106,647.00
October 2018
A Mouse Model of HIST1H3B/ACVR1 Mutant DIPG.

Johns Hopkins Children's Center - $50,000
$50,000.00
July 2018
Using Zebrafish to Accelerate DIPG Drug Development.

Funding of PBTCF 2018: PBTC-058 - $16,800
$16,800.00
January 2018
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

The Campbell Family Institute for Cancer Research - $100,000
$100,000.00
October 2017
Defining the molecular mechanisms of DIPG development and progression to uncover novel therapeutic targets